c


     
    
  



   
     
 !" # $%

&''

GBI Research, the leading business intelligence provider, has released its latest research
³Hospital Acquired Bacterial Infections Market to 2016 - Increasing Antibiotic Resistance and
Increasing Population of Critically Ill Patients To Drive Growth´. The report provides in-depth
analysis of drivers and barriers that impact the global hospital acquired bacterial infections
(HABI) market. The report analyzes the markets for hospital acquired bacterial infections in the
US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan.
Treatment usage patterns, sales, prices are forecast until 2016 for the key geographies as well as
the leading therapeutic segments. Further, the report provides competitive benchmarking for the
leading companies and analyzes the mergers, acquisitions and licensing agreements that shape
the global markets.

& 

The scope of this report includes:

- Annualized market data for the HABI market from 2001 to 2009, forecast forward to 2016.
- Analysis of the leading therapeutic segments, including UTI, Pneumonia, SSI and BSI.
- Analysis of the HABI market in the leading geographies of the world, which include the US,
the UK, Germany, France, Italy, Spain and Japan.
- Market characterization of the HABI market, including market size, annual cost of therapy and
treatment usage patterns.
- Key drivers and barriers that have a significant impact on the market.
- Competitive benchmarking of leading companies. The key companies studied in this report are
Pfizer, Eli Lily, Astrazeneca, Hoffman-La-Roche, Abbott, Novo Nordisk and Warner and
Chilcott.
- Key M&A activities, licensing agreements, that have taken place since 2004 in HABI market.

    
(

1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7
2 Global Hospital Acquired Bacterial Infections Market: Introduction 10
2.1 GBI Research Report Guidance 10
3 Global Hospital Acquired Bacterial Infections Market: Market Overview 11
3.1 Introduction 11
3.2 Revenue Forecasts for the Global Hospital Acquired Bacterial Infections Market 12
3.2.1 Sales Value 12
3.2.2 Annual Cost of Therapy 13
3.2.3 Treatment Usage Patterns 14
3.3 Hospital Acquired Bacterial Infections Market Drivers 18
3.3.1 Steady Increase in Elderly and Immuno-Suppressed Population 18
3.3.2 Increase in Average Number of Days Spent In Hospitals 18
3.3.3 Patent Expiries of Branded Drugs Will Make Them More Affordable 18
3.4 Hospital Acquired Bacterial Infections Market Restraints 18
3.4.1 Increased Penetration of Generics Pose a Serious Threat for Primary Manufacturers 18
3.4.2 Increased Anti-bacterial Surveillance in Hospitals 18
4 Global Hospital Acquired Bacterial Infections Market: Therapeutic Landscape 19
4.1 Hospital Acquired Urinary Tract Infections (UTI) Market 19
4.1.1 Introduction 19
4.1.2 Sales Value 19
4.1.3 Annual Cost of Therapy 21
4.1.4 Treatment Usage Patterns 22
4.1.5 Market Share by Geography 26
4.2 Hospital Acquired Bacterial Pneumonia Market 28
4.2.1 Introduction 28
4.2.2 Sales Value 28
4.2.3 Annual Cost of Therapy 30
4.2.4 Treatment Usage Patterns 31
4.2.5 Market Share by Geography 35
4.3 Hospital Acquired Bacterial Surgical Site Infections Market 37
4.3.1 Introduction 37
4.3.2 Sales Value 37
4.3.3 Annual Cost of Therapy 38
4.3.4 Treatment Usage Patterns 39
4.3.5 Market Share by Geography 43
4.4 Hospital Acquired Bacterial Blood Stream Infections (BSI) Market 45
4.4.1 Introduction 45
4.4.2 Sales Value 45
4.4.3 Annual Cost of Therapy 46
4.4.4 Treatment Usage Patterns 47
4.4.5 Market Share by Geography 51
5 Global Hospital Acquired Bacterial Infections Market: Geographical Landscape 54
5.1 Geographical Break-up 54
5.2 The US 56
5.2.1 Sales Value 56
5.2.2 Annual Cost of Therapy 57
5.2.3 Treatment Usage Patterns 58
5.3 Top Five Countries in Europe 62
5.3.1 Sales Value 62
5.3.2 Annual Cost of Therapy 63
5.3.3 Treatment Usage Patterns 64
5.4 Japan 68
5.4.1 Sales Value 68
5.4.2 Annual Cost of Therapy 69
5.4.3 Treatment Usage Patterns 70

V '   ' ) 
"
(

%(**$$$+
  + '*  
*c

     
  
  
  

   
     
 
!" # $%,--.+%'

    
(

Offshore Rig Construction Market to 2015 - Premium Jack-up Segment Witnessing High Growth
Despite Massive Supplies During the Rig Construction Boom
In-vitro and Companion Diagnostics Industry - 2010 Yearbook
Computed Tomography (CT) Systems Market to 2016 - The High Slice Segment to be the Key
Revenue Generator
X-Ray Systems Market to 2016 - The Digital X-Ray Systems Segment to be the Growth Driver
Geothermal Power Market in Americas to 2020 - High Potential along with Favorable Policies
Propelling The US Market
Healthcare System and Delivery Network ± 2010 Yearbook
Emerging Markets for Clinical Trials in India - Favorable Regulatory Environment and Cost
Effectiveness Will Accelerate the Number of Clinical Trials